Vanguard Group Inc Windtree Therapeutics Inc Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Shares
6 transactions
Others Institutions Holding WINT
# of Institutions
2Shares Held
4.09KCall Options Held
0Put Options Held
0About WINDTREE THERAPEUTICS INC
- Ticker WINT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,627,900
- Market Cap $22.1M
- Description
- Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...